UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 155

Sortiert nach

The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury

Cardiovascular research, 2013-07, Vol.99 (1), p.164-174

2013

Volltextzugriff (PDF)

Inflammatory Cytokines in Heart Failure: Mediators and Markers

Cardiology, 2012-01, Vol.122 (1), p.23-35

2012

Volltextzugriff (PDF)

NLRP3 Inflammasome Expression and Activation in Human Atherosclerosis

Journal of the American Heart Association, 2016-05, Vol.5 (5), p.n/a

2016

Volltextzugriff (PDF)

NLRP3 inflammasome mediates oxidative stress-induced pancreatic islet dysfunction

American journal of physiology: endocrinology and metabolism, 2018-11, Vol.315 (5), p.E912-E923

2018

Volltextzugriff (PDF)

Instability in NAD+ metabolism leads to impaired cardiac mitochondrial function and communication

eLife, 2021-08, Vol.10

2021

Volltextzugriff (PDF)

S775 Major Cardiovascular Adverse Events by Baseline Cardiovascular Risk Stratification in Patients With Ulcerative Colitis Treated With Tofacitinib: Data From the OCTAVE Clinical Program

The American journal of gastroenterology, 2022-10, Vol.117 (10S), p.e551-e552

2022

Volltextzugriff (PDF)

Association between baseline cardiovascular risk and incidence rates of major adverse cardiovascular events and malignancies in patients with psoriatic arthritis and psoriasis receiving tofacitinib

Therapeutic advances in musculoskeletal disease, 2023-01, Vol.15, p.1759720X221149965-1759720X221149965

2023

Volltextzugriff (PDF)

Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies

European journal of endocrinology, 2012-03, Vol.166 (3), p.503

2012

Volltextzugriff (PDF)

Rosuvastatin alters the genetic composition of the human gut microbiome

Scientific reports, 2020-03, Vol.10 (1), p.5397, Article 5397

2020

Volltextzugriff (PDF)

Wnt5a is associated with right ventricular dysfunction and adverse outcome in dilated cardiomyopathy

Scientific reports, 2017-06, Vol.7 (1), p.3490-10, Article 3490

2017

Volltextzugriff (PDF)

NLRP3 Inflammasome Promotes Myocardial Remodeling During Diet-Induced Obesity

Frontiers in immunology, 2019, Vol.10, p.1621-1621

2019

Volltextzugriff (PDF)

Increased circulating mitochondrial DNA after myocardial infarction

International journal of cardiology, 2012-06, Vol.158 (1), p.132-134

2012

Volltextzugriff (PDF)

Low Circulating Levels of Mitochondrial and High Levels of Nuclear DNA Predict Mortality in Chronic Heart Failure

Journal of cardiac failure, 2016-10, Vol.22 (10), p.823-828

2016

Volltextzugriff (PDF)

Dysregulated osteoprotegerin/RANK ligand/RANK axis in clinical and experimental heart failure

Circulation (New York, N.Y.), 2005-05, Vol.111 (19), p.2461-2468

2005

Volltextzugriff (PDF)

Low fibre intake is associated with gut microbiota alterations in chronic heart failure

ESC Heart Failure, 2020-04, Vol.7 (2), p.456-466

2020

Volltextzugriff (PDF)

Intracellular Nicotinamide Phosphoribosyltransferase Protects against Hepatocyte Apoptosis and Is Down-Regulated in Nonalcoholic Fatty Liver Disease

The journal of clinical endocrinology and metabolism, 2010-06, Vol.95 (6), p.3039-3047

2010

Volltextzugriff (PDF)

Mammalian Target of Rapamycin (mTOR) and the Proteasome Attenuates IL-1β Expression in Primary Mouse Cardiac Fibroblasts

Frontiers in immunology, 2019, Vol.10, p.1285-1285

2019

Volltextzugriff (PDF)

Secreted Frizzled Related Protein 3 in Chronic Heart Failure: Analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)

PloS one, 2015-08, Vol.10 (8), p.e0133970-e0133970

2015

Volltextzugriff (PDF)

Risk of extended major adverse cardiovascular event endpoints with tofacitinib versus TNF inhibitors in patients with rheumatoid arthritis: a post hoc analysis of a phase 3b/4 randomised safety study

Rheumatic & musculoskeletal diseases open, 2024-04, Vol.10 (2), p.e003912

2024

Volltextzugriff (PDF)

Platelet-derived LIGHT induces inflammatory responses in endothelial cells and monocytes

Blood, 2006-08, Vol.108 (3), p.928-935

2006

Volltextzugriff (PDF)

Altered Levels of Fatty Acids and Inflammatory and Metabolic Mediators in Epicardial Adipose Tissue in Patients With Systolic Heart Failure

Journal of cardiac failure, 2015-11, Vol.21 (11), p.916-923

2015

Volltextzugriff (PDF)

Influenza Adverse Events in Patients with Rheumatoid Arthritis, Ulcerative Colitis, or Psoriatic Arthritis in the Tofacitinib Clinical Development Programs

Rheumatology and therapy., 2023-04, Vol.10 (2), p.357-373

2023

Volltextzugriff (PDF)

Testosterone: A Novel Therapeutic Approach in Chronic Heart Failure?

Journal of the American College of Cardiology, 2009-09, Vol.54 (10), p.928-929

2009

Volltextzugriff (PDF)

Absence of NLRP3 Inflammasome in Hematopoietic Cells Reduces Adverse Remodeling After Experimental Myocardial Infarction

JACC. Basic to translational science, 2020-12, Vol.5 (12), p.1210-1224

2020

Volltextzugriff (PDF)

A vital role for complement in heart disease

Molecular immunology, 2014-10, Vol.61 (2), p.126-134

2014

Volltextzugriff (PDF)

1 – 25 von 155

Suche als RSS-Feed

Aktive Filter

KollektionNexis Uni

ThemaInflammation

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(149)
Mit Volltextzugriff
(140)

Publikationsform

Artikel
(152)
Buchkapitel
(3)

Sprache

Englisch
(141)
Norwegisch
(20)
Japanisch
(18)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury

Inflammatory Cytokines in Heart Failure: Mediators and Markers

NLRP3 Inflammasome Expression and Activation in Human Atherosclerosis

NLRP3 inflammasome mediates oxidative stress-induced pancreatic islet dysfunction

Instability in NAD+ metabolism leads to impaired cardiac mitochondrial function and communication

S775 Major Cardiovascular Adverse Events by Baseline Cardiovascular Risk Stratification in Patients With Ulcerative Colitis Treated With Tofacitinib: Data From the OCTAVE Clinical Program

Association between baseline cardiovascular risk and incidence rates of major adverse cardiovascular events and malignancies in patients with psoriatic arthritis and psoriasis receiving tofacitinib

Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies

Rosuvastatin alters the genetic composition of the human gut microbiome

Wnt5a is associated with right ventricular dysfunction and adverse outcome in dilated cardiomyopathy

NLRP3 Inflammasome Promotes Myocardial Remodeling During Diet-Induced Obesity

Increased circulating mitochondrial DNA after myocardial infarction

Low Circulating Levels of Mitochondrial and High Levels of Nuclear DNA Predict Mortality in Chronic Heart Failure

Dysregulated osteoprotegerin/RANK ligand/RANK axis in clinical and experimental heart failure

Low fibre intake is associated with gut microbiota alterations in chronic heart failure

Intracellular Nicotinamide Phosphoribosyltransferase Protects against Hepatocyte Apoptosis and Is Down-Regulated in Nonalcoholic Fatty Liver Disease

Mammalian Target of Rapamycin (mTOR) and the Proteasome Attenuates IL-1β Expression in Primary Mouse Cardiac Fibroblasts

Secreted Frizzled Related Protein 3 in Chronic Heart Failure: Analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)

Risk of extended major adverse cardiovascular event endpoints with tofacitinib versus TNF inhibitors in patients with rheumatoid arthritis: a post hoc analysis of a phase 3b/4 randomised safety study

Platelet-derived LIGHT induces inflammatory responses in endothelial cells and monocytes

Altered Levels of Fatty Acids and Inflammatory and Metabolic Mediators in Epicardial Adipose Tissue in Patients With Systolic Heart Failure

Influenza Adverse Events in Patients with Rheumatoid Arthritis, Ulcerative Colitis, or Psoriatic Arthritis in the Tofacitinib Clinical Development Programs

Testosterone: A Novel Therapeutic Approach in Chronic Heart Failure?

Absence of NLRP3 Inflammasome in Hematopoietic Cells Reduces Adverse Remodeling After Experimental Myocardial Infarction

A vital role for complement in heart disease

Aktive Filter

Suchergebnisse filtern